1. Ponnusamy KE, Kim TJ, Khanuja HS. Perioperative
blood transfusions in orthopaedic surgery. J Bone
Joint Surg Am. 2014; 96(21):1836-44.
2. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK,
Trout R, et al. Effect of anaemia and cardiovascular
disease on surgical mortality and morbidity. The
Lancet. 1996; 348(9034):1055-60.
3. Levy JH, Koster A, Quinones QJ, Milling TJ, Key
NS. Antifibrinolytic therapy and perioperative
considerations. Anesthesiology. 2018; 128(3):657-70.
4. Xie J, Ma J, Yue C, Kang P, Pei F. Combined use of
intravenous and topical tranexamic acid following
cementless total hip arthroplasty: a randomised
clinical trial. Hip International. 2016; 26(1):36-42.
5. Sridharan K, Sivaramakrishnan G. Tranexamic acid
in total hip arthroplasty: a recursive cumulative
meta-analysis of randomized controlled trials
and assessment of publication bias. Journal of
orthopaedics. 2017; 14(3):323-8.
6. Kozek-Langenecker SA, Ahmed AB, Afshari A,
Albaladejo P, Aldecoa C, Barauskas G, et al. Management
of severe perioperative bleeding: guidelines from the
European Society of Anaesthesiology: first update
2016. European Journal of Anaesthesiology| EJA.
2017; 34(6):332-95.
7. Nishihara S, Hamada M. Does tranexamic acid
alter the risk of thromboembolism after total hip
arthroplasty in the absence of routine chemical
thromboprophylaxis? The Bone & Joint Journal. 2015;
97(4):458-62.
8. Fillingham YA, Kayupov E, Plummer DR, Moric M,
Gerlinger TL, Della Valle CJ. The James A. Rand Young
Investigator’s Award: a randomized controlled trial
of oral and intravenous tranexamic acid in total knee
arthroplasty: the same efficacy at lower cost? The
Journal of arthroplasty. 2016; 31(9):26-30.
9. Luo ZY, Wang HY, Wang D, Zhou K, Pei FX, Zhou ZK. Oral
vs intravenous vs topical tranexamic acid in primary
hip arthroplasty: a prospective, randomized, doubleblind, controlled study. The Journal of arthroplasty.
2018; 33(3):786-93.
10.Turner RM, Park BK, Pirmohamed M. Parsing
interindividual drug variability: an emerging role
for systems pharmacology. Wiley Interdisciplinary
Reviews: Systems Biology and Medicine. 2015;
7(4):221-41.
11.Sweeney GD. Variability in the human drug response.
Thrombosis Research. 1983; 29:3-15.
12.Gurunathan U. Staggered bilateral knee arthroplasty:
good or bad? Anesthesiology. 2010; 113(1):256-8.
13.Morris JK, Fincham BM. Intermittent pneumatic
compression for venous thromboembolism
prophylaxis in total knee arthroplasty. Orthopedics.
2012; 35(12):e1716-21.
14.Crawford DA, Andrews RL, Morris MJ, Hurst JM,
Lombardi Jr AV, Berend KR. Ambulatory portable
pneumatic compression device as part of a
multimodal aspirin-based approach in prevention of
venous thromboembolism in outpatient total knee
arthroplasty. Arthroplasty today. 2020; 6(3):378-80.
15.Algadiem EA, Aleisa AA, Alsubaie HI, Buhlaiqah NR,
Algadeeb JB, Alsneini HA. Blood loss estimation using
gauze visual analogue. Trauma monthly. 2016; 21(2).
16.Gao FQ, Li ZJ, Zhang K, Sun W, Zhang H. Four methods
for calculating blood-loss after total knee arthroplasty.
Chinese medical journal. 2015; 128(21):2856-60. 17.Jansen AJ, Andreica S, Claeys M, D’haese J, Camu F,
Jochmans K. Use of tranexamic acid for an effective
blood conservation strategy after total knee
arthroplasty. British journal of Anaesthesia. 1999;
83(4):596-601.
18.Benoni G, Fredin HA. Fibrinolytic inhibition with
tranexamic acid reduces blood loss and blood
transfusion after knee arthroplasty: a prospective,
randomised, double-blind study of 86 patients. The
Journal of bone and joint surgery. British volume.
1996; 78(3):434-40.
19.Irwin A, Khan SK, Jameson SS, Tate RC, Copeland C,
Reed MR. Oral versus intravenous tranexamic acid
in enhanced-recovery primary total hip and knee
replacement: results of 3000 procedures. The Bone &
Joint Journal. 2013; 95(11):1556-61.
20.Jules-Elysee KM, Tseng A, Sculco TP, Baaklini LR,
McLawhorn AS, Pickard AJ, et al. Comparison of
topical and intravenous tranexamic acid for total
knee replacement: a randomized double-blinded
controlled study of effects on tranexamic acid levels
and thrombogenic and inflammatory marker levels.
The Journal of bone and joint surgery. American
volume. 2019; 101(23):2120.
21.Guo P, He Z, Wang Y, Gao F, Sun W, Guo W, et al. Efficacy
and safety of oral tranexamic acid in total knee
arthroplasty: a systematic review and meta-analysis.
Medicine. 2018; 97(18).
22.Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ,
Shores P, Mullen K, et al. The efficacy of tranexamic acid
in total knee arthroplasty: a network meta-analysis.
The Journal of arthroplasty. 2018; 33(10):3090-8.
23.Xiong H, Liu Y, Zeng Y, Wu Y, Shen B. The efficacy and
safety of combined administration of intravenous
and topical tranexamic acid in primary total knee
arthroplasty: a meta-analysis of randomized
controlled trials. BMC musculoskeletal disorders.
2018; 19(1):1-1.
24.Wang D, Luo ZY, Yu ZP, Liu LX, Chen C, Meng WK, et
al. The antifibrinolytic and anti‐inflammatory effects
of multiple doses of oral tranexamic acid in total
knee arthroplasty patients: a randomized controlled
trial. Journal of Thrombosis and Haemostasis. 2018;
16(12):2442-53.
)